Purchase Order 75N91025P00426

<p>The National Cancer Institute, a civilian federal agency, awarded a firm-fixed-price purchase order contract worth $14,500.00 to Labcorp Genetics Inc. for genetic testing services. The contract has an ultimate completion date of October 31, 2025 and was awarded on April 30, 2025. This contract award is not associated with a larger contract vehicle and does not have a set-aside designation.</p>

This firm-fixed-price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian federal agency, to Laboratory Corporation of America (LabCorp) for the provision of noninvasive prenatal testing (NIPT) services. The contract, which does not have a set-aside designation, has a ceiling value of $24,950.00 and an ultimate completion date of September 30, 2024. LabCorp, a leading global life sciences company, is the prime contractor and will deliver a range of...

This is a federal contract award to Laboratory Corporation of America (Labcorp), a leading global life sciences company, by the National Human Genome Research Institute (NHGRI), a civilian agency under the Department of Health and Human Services. The contract, valued at $62,375.00, is a firm-fixed-price Delivery Order under Labcorp's General Services Administration (GSA) Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services (FSS-621-II). The contract is not set...

This is a federal contract award to Laboratory Corporation of America (LabCorp), a major life sciences company, to provide non-invasive prenatal testing (NIPT) services. The contract, valued at $35,928, was issued by the National Human Genome Research Institute, a civilian agency, through the Medical Laboratory Testing and Analysis Services (FSS-621-II) schedule under the General Services Administration (GSA). The contract is a delivery order, with a firm fixed-price pricing type and an ultimate...

The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Genus Biosystems Inc., a for-profit organization, for $23,520.00 to provide lab testing services. The contract has a completion date of November 1, 2024 and was awarded on May 1, 2024. The place of performance is Northbrook, IL 60062, USA. This contract award is not associated with any set-aside designation.</p>

This federal contract award, with an ID of HHSN273201500005I|75N96019F00038, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to the Laboratory Corporation of America (Labcorp), a for-profit organization. The contract, valued at $156,200.00, is for a Delivery Order under the &quot;NEXTGEN SEQUENCING &amp; OMICS SERVICES&quot; program, with a period of performance ending on August 31, 2020. The contract is a Firm Fixed Price arrangement and was not...

This is a firm fixed-price delivery order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Laboratory Corporation of America (Labcorp), a leading global life sciences company. The $164,894 contract is for &quot;NEXTGEN SEQUENCING AND OMICS SERVICES&quot; with an ultimate completion date of August 30, 2017. Labcorp, the prime contractor, has a strong track record of providing comprehensive clinical laboratory services to federal agencies, including...

This is a firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Labcorp Early Development Laboratories Inc., a for-profit subsidiary of Laboratory Corporation of America Holdings. The contract, valued at $113,830.32, is for the company to perform whole genome DNA methylation profiling and genotyping on 580 DNA samples. The work is to be conducted at the contractor's facility in...

This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, to provide laboratory testing and quality assurance services for the LMB-100 drug product. The objective is to conduct the required testing and assays to support the Investigational New Drug (IND) application for LMB-100, an anti-mesothelin immunotoxin being developed by NCI's Laboratory of Molecular...